Patnaik A - Search Results

1

A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors.

Papadopoulos KP, Kelley RK, Tolcher AW, Razak AR, Van Loon K, Patnaik A, Bedard PL, Alfaro AA, Beeram M, Adriaens L, Brownstein CM, Lowy I, Kostic A, Trail PA, Gao B, DiCioccio AT, Siu LL. Papadopoulos KP, et al. Among authors: patnaik a. Clin Cancer Res. 2016 Mar 15;22(6):1348-55. doi: 10.1158/1078-0432.CCR-15-1221. Epub 2015 Oct 21. Clin Cancer Res. 2016. PMID: 26490310 Clinical Trial.

2

Phase I/II trial of cyclophosphamide, mitoxantrone, and escalated doses of carboplatin supported by peripheral-blood stem cells in women with metastatic breast cancer.

Patnaik A, MacKinnon J, Goss P, Nagy T, Stewart K, Keating A, Crump M. Patnaik A, et al. J Clin Oncol. 2000 Jun;18(12):2363-8. doi: 10.1200/JCO.2000.18.12.2363. J Clin Oncol. 2000. PMID: 10856095 Clinical Trial.

3

Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors.

Patnaik A, Warner E, Michael M, Egorin MJ, Moore MJ, Siu LL, Fracasso PM, Rivkin S, Kerr I, Litchman M, Oza AM. Patnaik A, et al. J Clin Oncol. 2000 Nov 1;18(21):3677-89. doi: 10.1200/JCO.2000.18.21.3677. J Clin Oncol. 2000. PMID: 11054441 Clinical Trial.

4

Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancer.

Patnaik A, Rowinsky EK, Tammara BK, Hidalgo M, Drengler RL, Garner AM, Siu LL, Hammond LA, Felton SA, Mallikaarjun S, Von Hoff DD, Eckhardt SG. Patnaik A, et al. J Clin Oncol. 2000 Dec 1;18(23):3974-85. doi: 10.1200/JCO.2000.18.23.3974. J Clin Oncol. 2000. PMID: 11099327 Clinical Trial.

5

Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.

Tolcher AW, Eckhardt SG, Kuhn J, Hammond L, Weiss G, Rizzo J, Aylesworth C, Hidalgo M, Patnaik A, Schwartz G, Felton S, Campbell E, Rowinsky EK. Tolcher AW, et al. Among authors: patnaik a. J Clin Oncol. 2001 Jun 1;19(11):2937-47. doi: 10.1200/JCO.2001.19.11.2937. J Clin Oncol. 2001. PMID: 11387367 Clinical Trial.

6

A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignancies.

Britten CD, Rowinsky EK, Soignet S, Patnaik A, Yao SL, Deutsch P, Lee Y, Lobell RB, Mazina KE, McCreery H, Pezzuli S, Spriggs D. Britten CD, et al. Among authors: patnaik a. Clin Cancer Res. 2001 Dec;7(12):3894-903. Clin Cancer Res. 2001. PMID: 11751480 Clinical Trial.

7

Troxacitabine, an L-stereoisomeric nucleoside analog, on a five-times-daily schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies.

de Bono JS, Stephenson J Jr, Baker SD, Hidalgo M, Patnaik A, Hammond LA, Weiss G, Goetz A, Siu L, Simmons C, Jolivet J, Rowinsky EK. de Bono JS, et al. Among authors: patnaik a. J Clin Oncol. 2002 Jan 1;20(1):96-109. doi: 10.1200/JCO.2002.20.1.96. J Clin Oncol. 2002. PMID: 11773159 Clinical Trial.

8

A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.

Patnaik A, Rowinsky EK, Villalona MA, Hammond LA, Britten CD, Siu LL, Goetz A, Felton SA, Burton S, Valone FH, Eckhardt SG. Patnaik A, et al. Clin Cancer Res. 2002 Jul;8(7):2142-8. Clin Cancer Res. 2002. PMID: 12114414 Review.

9

A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies.

Rowinsky EK, Rizzo J, Ochoa L, Takimoto CH, Forouzesh B, Schwartz G, Hammond LA, Patnaik A, Kwiatek J, Goetz A, Denis L, McGuire J, Tolcher AW. Rowinsky EK, et al. Among authors: patnaik a. J Clin Oncol. 2003 Jan 1;21(1):148-57. doi: 10.1200/JCO.2003.03.143. J Clin Oncol. 2003. PMID: 12506184 Clinical Trial.

10

Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics.

Beeram M, Patnaik A. Beeram M, et al. Among authors: patnaik a. Hematol Oncol Clin North Am. 2002 Oct;16(5):1089-100. doi: 10.1016/s0889-8588(02)00054-0. Hematol Oncol Clin North Am. 2002. PMID: 12512384 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters